Do African-American men need separate prostate cancer screening guidelines?

Divya Shenoy, Satyaseelan Packianathan, Allen M. Chen, Srinivasan Vijayakumar

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: In 2012, the United States Preventative Services Task Force issued new guidelines recommending that male U.S. residents, irrespective of race, no longer be screened for prostate cancer. In African American men, the incidence of prostate cancer is almost 60 % higher and the mortality rate is two to three times greater than in Caucasians. The purpose of this study is to reduce African American men's prostate cancer burden by demonstrating they need separate screening guidelines. Methods: We performed a PubMed search using the keywords: African American, Prostate cancer, Outcomes, Molecular markers, Prostate-specific Antigen velocity, PSA density, and to derive data relevant to our hypothesis. Results: In our literature review, we identified several aspects of prostate cancer that are different in Caucasian and African American men. These included prostate cancer incidence and outcome, the clinical course of the disease, serum PSA levels, genetic differences, and social barriers. It's also important to note that the USPSTF guidelines were based on two studies, one of which reported that only 4 % of its participants were African American. The other did not report demographic information, but used participants from seven European countries with small African American populations. Conclusion: Given the above, we conclude that separate prostate cancer screening guidelines are greatly necessary to help save the lives of African Americans.

Original languageEnglish (US)
Article number19
JournalBMC Urology
Volume16
Issue number1
DOIs
StatePublished - May 10 2016

Fingerprint

Early Detection of Cancer
African Americans
Prostatic Neoplasms
Guidelines
Incidence
Advisory Committees
Prostate-Specific Antigen
PubMed
Demography
Mortality
Serum
Population

Keywords

  • African Americans
  • Prostate cancer
  • Screening guidelines

ASJC Scopus subject areas

  • Reproductive Medicine
  • Urology

Cite this

Shenoy, D., Packianathan, S., Chen, A. M., & Vijayakumar, S. (2016). Do African-American men need separate prostate cancer screening guidelines? BMC Urology, 16(1), [19]. https://doi.org/10.1186/s12894-016-0137-7

Do African-American men need separate prostate cancer screening guidelines? / Shenoy, Divya; Packianathan, Satyaseelan; Chen, Allen M.; Vijayakumar, Srinivasan.

In: BMC Urology, Vol. 16, No. 1, 19, 10.05.2016.

Research output: Contribution to journalArticle

Shenoy, D, Packianathan, S, Chen, AM & Vijayakumar, S 2016, 'Do African-American men need separate prostate cancer screening guidelines?', BMC Urology, vol. 16, no. 1, 19. https://doi.org/10.1186/s12894-016-0137-7
Shenoy, Divya ; Packianathan, Satyaseelan ; Chen, Allen M. ; Vijayakumar, Srinivasan. / Do African-American men need separate prostate cancer screening guidelines?. In: BMC Urology. 2016 ; Vol. 16, No. 1.
@article{2eb4639eba1540929b8c46ca57f3b7af,
title = "Do African-American men need separate prostate cancer screening guidelines?",
abstract = "Background: In 2012, the United States Preventative Services Task Force issued new guidelines recommending that male U.S. residents, irrespective of race, no longer be screened for prostate cancer. In African American men, the incidence of prostate cancer is almost 60 {\%} higher and the mortality rate is two to three times greater than in Caucasians. The purpose of this study is to reduce African American men's prostate cancer burden by demonstrating they need separate screening guidelines. Methods: We performed a PubMed search using the keywords: African American, Prostate cancer, Outcomes, Molecular markers, Prostate-specific Antigen velocity, PSA density, and to derive data relevant to our hypothesis. Results: In our literature review, we identified several aspects of prostate cancer that are different in Caucasian and African American men. These included prostate cancer incidence and outcome, the clinical course of the disease, serum PSA levels, genetic differences, and social barriers. It's also important to note that the USPSTF guidelines were based on two studies, one of which reported that only 4 {\%} of its participants were African American. The other did not report demographic information, but used participants from seven European countries with small African American populations. Conclusion: Given the above, we conclude that separate prostate cancer screening guidelines are greatly necessary to help save the lives of African Americans.",
keywords = "African Americans, Prostate cancer, Screening guidelines",
author = "Divya Shenoy and Satyaseelan Packianathan and Chen, {Allen M.} and Srinivasan Vijayakumar",
year = "2016",
month = "5",
day = "10",
doi = "10.1186/s12894-016-0137-7",
language = "English (US)",
volume = "16",
journal = "BMC Urology",
issn = "1471-2490",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Do African-American men need separate prostate cancer screening guidelines?

AU - Shenoy, Divya

AU - Packianathan, Satyaseelan

AU - Chen, Allen M.

AU - Vijayakumar, Srinivasan

PY - 2016/5/10

Y1 - 2016/5/10

N2 - Background: In 2012, the United States Preventative Services Task Force issued new guidelines recommending that male U.S. residents, irrespective of race, no longer be screened for prostate cancer. In African American men, the incidence of prostate cancer is almost 60 % higher and the mortality rate is two to three times greater than in Caucasians. The purpose of this study is to reduce African American men's prostate cancer burden by demonstrating they need separate screening guidelines. Methods: We performed a PubMed search using the keywords: African American, Prostate cancer, Outcomes, Molecular markers, Prostate-specific Antigen velocity, PSA density, and to derive data relevant to our hypothesis. Results: In our literature review, we identified several aspects of prostate cancer that are different in Caucasian and African American men. These included prostate cancer incidence and outcome, the clinical course of the disease, serum PSA levels, genetic differences, and social barriers. It's also important to note that the USPSTF guidelines were based on two studies, one of which reported that only 4 % of its participants were African American. The other did not report demographic information, but used participants from seven European countries with small African American populations. Conclusion: Given the above, we conclude that separate prostate cancer screening guidelines are greatly necessary to help save the lives of African Americans.

AB - Background: In 2012, the United States Preventative Services Task Force issued new guidelines recommending that male U.S. residents, irrespective of race, no longer be screened for prostate cancer. In African American men, the incidence of prostate cancer is almost 60 % higher and the mortality rate is two to three times greater than in Caucasians. The purpose of this study is to reduce African American men's prostate cancer burden by demonstrating they need separate screening guidelines. Methods: We performed a PubMed search using the keywords: African American, Prostate cancer, Outcomes, Molecular markers, Prostate-specific Antigen velocity, PSA density, and to derive data relevant to our hypothesis. Results: In our literature review, we identified several aspects of prostate cancer that are different in Caucasian and African American men. These included prostate cancer incidence and outcome, the clinical course of the disease, serum PSA levels, genetic differences, and social barriers. It's also important to note that the USPSTF guidelines were based on two studies, one of which reported that only 4 % of its participants were African American. The other did not report demographic information, but used participants from seven European countries with small African American populations. Conclusion: Given the above, we conclude that separate prostate cancer screening guidelines are greatly necessary to help save the lives of African Americans.

KW - African Americans

KW - Prostate cancer

KW - Screening guidelines

UR - http://www.scopus.com/inward/record.url?scp=84969185739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969185739&partnerID=8YFLogxK

U2 - 10.1186/s12894-016-0137-7

DO - 10.1186/s12894-016-0137-7

M3 - Article

AN - SCOPUS:84969185739

VL - 16

JO - BMC Urology

JF - BMC Urology

SN - 1471-2490

IS - 1

M1 - 19

ER -